CIK 0001827635 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Veradermics, Inc
Sign in to watch- Ticker
- MANE
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 843304423
- Phone
- 228.372.3376
- Business address
- 470 JAMES STREET, NEW HAVEN, CT, 06513
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $242,788,217
- in 5 filings, $12.0M under 10b5-1 plans
Net −$242,788,217. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- MONTANOVA CAPITAL, LLC −$80.4M Director sold 62% of stake
- ENRIGHT PATRICK G −$75.2M Director sold 22% of stake
- Longitude Capital Partners V, LLC −$75.2M 10% owner sold 22% of stake
- Waldman Reid Alexander −$7.3M Chief Executive Officer sold 28% of stake
- Durso Timothy August −$4.7M Chief Technical Officer sold 36% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-03 | ENRIGHT PATRICK G Director | Grant or award · Stock Option (Right to Buy) | +45,131 | 45,131 | ||
| 2026-02-03 | Greco Michael V. General Counsel | Grant or award · Stock Option (Right to Buy) | +144,401 | 144,401 | ||
| 2026-02-03 | Neumann Mark Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +102,885 | 102,885 | ||
| 2026-02-03 | Carrano Dominic Gabriel Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +148,011 | 148,011 | ||
| 2026-02-03 | Durso Timothy August Chief Technical Officer | Grant or award · Stock Option (Right to Buy) | +213,352 | 213,352 | ||
| 2026-02-03 | Waldman Reid Alexander Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +556,399 | 556,399 | ||
| 2026-02-03 | Pance Katarina Director | Grant or award · Stock Option (Right to Buy) | +43,000 | 43,000 |
Page 6 of 6 · 107 trades